SARS-CoV-2 |
severe acute respiratory syndrome- corona virus-2 |
SARS |
severe acute respiratory syndrome |
ACE2 |
angiotensin-converting enzyme 2 |
IL |
interleukins |
IF |
interferons |
TNF |
tumor necrosis factors |
TGF |
transforming growth factors |
CSF |
colony-stimulating factors |
LPL |
lipoprotein lipase |
ATGL |
adipocyte triglyceride lipase |
CRP |
C- reactive protein |
ICU |
intensive care unit |
CIF |
cachexia- inducing factors |
CRC |
colorectal cancer |
TAMs |
tumor-associated macrophages |
MCP1 |
monocyte chemoattractant protein 1 |
ACTRIIB |
activin receptor type IIB |
NFB |
nuclear factor B |
CHO |
Chinese hamster ovary |
CRH |
corticotrophin-releasing hormone |
TNFR1 |
TNF-α-receptor protein type I |
ECM |
extracellular matrix |
RyR |
ryanodine receptor5 |
LSMM |
low skeletal muscle mass |
SMM |
skeletal muscle mass |
CT |
computed tomography |
MERS |
middle east respiratory syndrome |
Th1 |
T helper 1 |
ARDS |
acute respiratory distress syndrome |
CRP |
C-reactive protein |
FDA |
Food and Drug Administration |
NSCLC |
non-small cell lung carcinoma |
MIC1 |
macrophage inhibitory cytokine 1 |
SNP |
single-nucleotide polymorphisms |